Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $7.60 and traded as low as $7.02. Bavarian Nordic A/S shares last traded at $7.03, with a volume of 722 shares trading hands.
Bavarian Nordic A/S Price Performance
The company has a market capitalization of $1.63 billion, a PE ratio of 7.32 and a beta of 1.50. The company has a 50 day moving average of $7.65 and a two-hundred day moving average of $7.59.
Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) last issued its quarterly earnings results on Wednesday, March 6th. The company reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.12. The company had revenue of $353.27 million during the quarter, compared to analysts’ expectations of $340.71 million. Bavarian Nordic A/S had a net margin of 20.80% and a return on equity of 0.07%. On average, equities analysts anticipate that Bavarian Nordic A/S will post 0.57 EPS for the current year.
Bavarian Nordic A/S Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Read More
- Five stocks we like better than Bavarian Nordic A/S
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Comprehensive Analysis of PayPal Stock
- Business Services Stocks Investing
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- How to Invest in the FAANG Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.